Company · CIK 0001349929
Vyant Bio, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001493152-23-016068 · 209.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-013369 · 253.7 KBSEC(opens sec.gov)
- 10-KAnnual report0001493152-23-010255 · 11.0 MBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-008809 · 221.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-008488 · 216.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-007670 · 517.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-007350 · 210.6 KBSEC(opens sec.gov)
- SC 13G/AVyant Bio, Inc.0001104659-23-020841 · 67.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-003456 · 258.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-23-000445 · 834.2 KBSEC(opens sec.gov)
Insiders
- Boehm MarcusDirector
- Brandt RalfPresident, Discovery Services
- Brownlie Keith LDirector
- Cannon EdmundDirector
- Chaganti Raju S.K.Director
- CZEREPAK ELIZABETHChief Financial Officer
- El Naggar Jane HouldsworthVP of Research and Development
- Finger William LansingEVP Precision Medicine
- FLETCHER R JOHNDirector
- Fremeau Robert Thomas Jr.Chief Scientific Officer
Tickers
No tickers on record.
Addresses
business
2370 STATE ROUTE 70 WEST SUITE 310
CHERRY HILL,, NJ, 08002
mailing
2370 STATE ROUTE 70 WEST SUITE 310
CHERRY HILL,, NJ, 08002
Former names
- CANCER GENETICS, INC2021-03-31
- CANCER GENETICS INC2010-11-01
Same industry